Ipca Laboratory Gains Panels To Consider Merging Tonira Pharma

The announcement was made at noon today, September 9, 2011.

Meanwhile, the BSE Sensex down 74.15 points, or 0.43%, to 17,091.39.

On BSE, 12,974 shares were traded in the counter compared to the average volume of 3,826 shares over the last two weeks NRI online trading account.

The stock reached a high of Rs 319.95 and low of Rs 314 so far during the day.

IPCA had 32.3% of the shares Tonira Pharma as of June 30, 2011. Actions Tonira Pharma hit the upper circuit of 20% to Rs 22.50 on BSE.

Net income IPCA Laboratories rose 58.78% to 61.67 crore rupees to the 27% increase in net sales to RS 526.33 crore in the first quarter, in June 2011 at the First District in June 2010 NRI Demat account .

IPCA Laboratories is an integrated pharmaceutical company fully backward compatible with strong pressure on exports. It manufactures active pharmaceutical ingredients (API), which produces the base leg. IPCA is also one of the largest providers of these APIs and their intermediaries throughout the world PAN Card for NRI .


Comments are closed.